Jan Marini's Transformation Cream is designed to reverse skin sensitivity, visible signs of aging, damaged skin changes and help prevent broken capillaries.
Key technologies used in Jan Marini Transformation Cream include TGF Beta-1 (Transforming Growth Factor), Thymosin Beta-4, Pentapeptides GM and GD, and Vascular Epithelial Growth Factor, which act as cellular mediators by signaling certain activities that are necessary for maintaining young appearing healthy skin.
Also included are powerful antioxidants to assist in protecting against free radical damage, along with hyaluronic acid.
In addition to the benefits of its most active ingredients, the Cream itself is based in a uniquely fluffy, protective and hydrating complex that moisturizes drier skin without weight or shine.
Patients will experience immediate benefits as well as long-term measurable changes.
Jan Marini Transformation Cream may be used alone with resurfacing agents, sunscreens and antioxidants to maintain young appearing, healthy skin; and in combination with glycolic acid products, Retin-A/Retinol, other topical medications, moisturizers and makeup as part of more aggressive age management or skin damage reversal protocols.
Medical studies indicate that Transforming Growth Factor (TGF Beta-1) is unparalleled in enhancing the factors that are critical to healing as well as stimulating collagen and elastin production. Results are rapid and dramatic.
Ingredients are dosed using a new liposome delivery system pioneered by Jan Marini Skin Research. This micronized liposome technology is thousands of times smaller than conventional systems. Each carrier bead is 1/20th the size of a red blood cell.
The liposome structure is in a time released format so that the essential components of the Jan Marini Transformation Cream are targeted continuously and precisely over extended periods of time.
The line of technologically advanced Transformation Hydrators also includes Transformation Serum and Transformation Eye Cream.
TGF Cream utilizes Jan Marini TGF Beta-1, Thymosin Beta-4 and VGF Treatment Technologies.